Evidence map›Paper›PMID 33267773›Full record

ArticleBMC genomics2020

Detection of CRISPR-mediated genome modifications through altered methylation patterns of CpG islands.

M Heath Farris, Pamela A Texter, Agustin A Mora, Michael V Wiles, Ellen F Mac Garrigle, Sybil A Klaus, Kristine Rosfjord

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

M Heath FarrisThe MITRE Corporation, 7515 Colshire Drive, McLean, Virginia, 22102, USA. hfarris@mitre.org.ORCID http://orcid.org/0000-0002-0327-6681
Pamela A TexterThe MITRE Corporation, 7515 Colshire Drive, McLean, Virginia, 22102, USA.
Agustin A MoraThe MITRE Corporation, 7515 Colshire Drive, McLean, Virginia, 22102, USA.
Michael V WilesThe Jackson Laboratory, Technology Evaluation and Development, Bar Harbor, ME, USA.
Ellen F Mac GarrigleThe MITRE Corporation, 7515 Colshire Drive, McLean, Virginia, 22102, USA.
Sybil A KlausThe MITRE Corporation, 7515 Colshire Drive, McLean, Virginia, 22102, USA.
Kristine RosfjordThe MITRE Corporation, 7515 Colshire Drive, McLean, Virginia, 22102, USA.
Mitre (United States) · USJackson Laboratory · US

Funding

The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)UM1OD023222 · OD · JACKSON LABORATORY · PI ROBERT E BRAUN, Stephen A Murray · 2016 to 2026
$47.2M
NIH HHS UM1 OD023222
6 · The paper itself

Abstract

backgroundThe development and application of CRISPR technologies for the modification of the genome are rapidly expanding. Advances in the field describe new CRISPR components that are strategically engineered to improve the precision and reliability of CRISPR editing within the genome sequence. Genome modification using induced genome breaks that are targeted and mediated by CRISPR components leverage cellular mechanisms for repair like homology directed repair (HDR) to incorporate genomic edits with increased precision.

resultsIn this report, we describe the gain of methylation at typically hypomethylated CpG island (CGI) locations affected by the CRISPR-mediated incorporation of donor DNA using HDR mechanisms. With characterization of CpG methylation patterns using whole genome bisulfite sequencing, these CGI methylation disruptions trace the insertion of the donor DNA during the genomic edit. These insertions mediated by homology-directed recombination disrupt the generational methylation pattern stability of the edited CGI within the cells and their cellular lineage within the animal strain, persisting across generations. Our approach describes a statistically based workflow for indicating locations of modified CGIs and provides a mechanism for evaluating the directed modification of the methylome of the affected CGI at the CpG-level.

conclusionsWith advances in genome modification technology comes the need to detect the level and persistence of methylation change that modifications to the genomic sequence impose upon the collaterally edited methylome. Any modification of the methylome of somatic or germline cells could have implications for gene regulation mechanisms governed by the methylation patterns of CGI regions in the application of therapeutic edits of more sensitively regulated genomic regions. The method described here locates the directed modification of the mouse epigenome that persists over generations. While this observance would require supporting molecular observations such as direct sequence changes or gene expression changes, the observation of epigenetic modification provides an indicator that intentionally directed genomic edits can lead to collateral, unintentional epigenomic changes post modification with generational persistence.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsGenomeAnimalsCpG IslandsDNA MethylationEpigenomeGene EditingMiceReproducibility of ResultsCpG islandCRISPR genome editingEpigenetic modificationHomology-directed repairMethylation varianceNon-homologous end-joiningStatistical variance detection

Identifiers

PMID33267773
PMCPMC7709351
OpenAlexW3110162204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.